TY - JOUR
T1 - A pleiotropic–epistatic entangelement model of drug response
AU - Wang, Yu
AU - Sang, Mengmeng
AU - Feng, Li
AU - Gragnoli, Claudia
AU - Griffin, Christopher
AU - Wu, Rongling
N1 - Publisher Copyright:
© 2023 Elsevier Ltd
PY - 2023/11
Y1 - 2023/11
N2 - Because drug response is multifactorial, graph models are uniquely powerful for comprehending its genetic architecture. We deconstruct drug response into many different and interdependent sub-traits, with each sub-trait controlled by multiple genes that act and interact in a complicated manner. The outcome of drug response is the consequence of multileveled intertwined interactions between pleiotropic effects and epistatic effects. Here, we propose a general statistical physics framework to chart the 3D geometric network that codes how epistasis pleiotropically influences a complete set of sub-traits to shape body–drug interactions. This model can dissect the topological architecture of epistatically induced pleiotropic networks (EiPN) and pleiotropically influenced epistatic networks (PiEN). We analyze and interpret the practical implications of the pleiotropic–epistatic entanglement model for pharmacogenomic studies.
AB - Because drug response is multifactorial, graph models are uniquely powerful for comprehending its genetic architecture. We deconstruct drug response into many different and interdependent sub-traits, with each sub-trait controlled by multiple genes that act and interact in a complicated manner. The outcome of drug response is the consequence of multileveled intertwined interactions between pleiotropic effects and epistatic effects. Here, we propose a general statistical physics framework to chart the 3D geometric network that codes how epistasis pleiotropically influences a complete set of sub-traits to shape body–drug interactions. This model can dissect the topological architecture of epistatically induced pleiotropic networks (EiPN) and pleiotropically influenced epistatic networks (PiEN). We analyze and interpret the practical implications of the pleiotropic–epistatic entanglement model for pharmacogenomic studies.
UR - http://www.scopus.com/inward/record.url?scp=85173648863&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85173648863&partnerID=8YFLogxK
U2 - 10.1016/j.drudis.2023.103790
DO - 10.1016/j.drudis.2023.103790
M3 - Review article
C2 - 37758020
AN - SCOPUS:85173648863
SN - 1359-6446
VL - 28
JO - Drug Discovery Today
JF - Drug Discovery Today
IS - 11
M1 - 103790
ER -